Expanding Regional Airports Act

H.R.8412 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes. H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 2243 - Palliative Care and Hospice Education and Training Act; a bill amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care. S. 2140 - Patient Eligibility Restoration Act; a bill to amend the law relating to patent subject matter eligibility to establish that only specified subject matter (e.g., a natural process wholly independent of human activity) is ineligible for patenting. Comments in response to draft legislation titled the Drug Shortages Prevention and Mitigation Act Comments in relation to the establishment of a Brain and Spine Metastasis Month Comments in response to a request for information on appropriate use of artificial intelligence in healthcare Efforts related to breast screening recommendations by the United States Preventative Services Taskforce Policies related to ICD-10 codes for inflammatory breast cancer Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to reforms to the United States Preventative Services Taskforce Comments in response to Draft Guidance for Industry: Cancer Clinical Trial Eligibility Criteria: Performance Status (FDA-2024-D-1377); Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications (FDA-2024-D1376); Cancer Clinical Trial Eligibility Criteria: Laboratory Values (FDA-2024-D-1402)

Client expense: $70,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

legislation as it relates to airlines/airports- H.R.103 To prohibit the Secretary of Transportation, acting through the Administrator of the Federal Aviation Administration, from setting a requirement that air carriers and foreign air carriers must require an individual to test negative for COVID-19 to travel in air transportation on an air carrier, and for other purposes; . H.R.2558,S1255 To amend title 49, United States Code, to include a public airport in use by an air reserve station as a primary airport;S.1055 Airport Infrastructure Resilience Act of 2023; H.R.1499 and S753 Good Jobs for Good Airports Act; S.1046 - Small Airport Regulation Relief Act of 2023; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; H.R.1049 Protecting Airport Communities from Particle Emissions Act; H.R.2467 Supporting Middle Americas Airports Act; H.R.2916 Expanding Regional Airports Act; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; S.615 Cabin Air Safety Act of 2023; S.1939 FAA Reauthorization Act of 2023; S.1550 Lower Fees, Better Airports Act of 2023;H.R.3896, S 1055 Airport Infrastructure Resilience Act of 2023; S.641 FREEBIRD Act; H.R.125 Travel Mask Mandate Repeal Act of 2023; NDAA 2025.

Client expense: Not reported · Firm income: $20,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 2243 - Palliative Care and Hospice Education and Training Act; a bill amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care. S. 2140 - Patient Eligibility Restoration Act; a bill to amend the law relating to patent subject matter eligibility to establish that only specified subject matter (e.g., a natural process wholly independent of human activity) is ineligible for patenting. Comments related to healthcare affordability Efforts related to breast screening recommendations by the United States Preventative Services Taskforce Efforts to preserve protections in the Affordable Care Act (ACA) for LGBTQ+ patients Policies related to ICD-10 codes for inflammatory breast cancer Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to reforms to the United States Preventative Services Taskforce

legislation as it relates to airlines/airports- H.R.103 To prohibit the Secretary of Transportation, acting through the Administrator of the Federal Aviation Administration, from setting a requirement that air carriers and foreign air carriers must require an individual to test negative for COVID-19 to travel in air transportation on an air carrier, and for other purposes; . H.R.2558,S1255 To amend title 49, United States Code, to include a public airport in use by an air reserve station as a primary airport;S.1055 Airport Infrastructure Resilience Act of 2023; H.R.1499 and S753 Good Jobs for Good Airports Act; S.1046 - Small Airport Regulation Relief Act of 2023; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; H.R.1049 Protecting Airport Communities from Particle Emissions Act; H.R.2467 Supporting Middle Americas Airports Act; H.R.1499 and S753 - Good Jobs for Good Airports Act; H.R.2670 National Defense Authorization Act for Fiscal Year 2024 S.2226 National Defense Authorization Act for Fiscal Year 2024; H.R.2916 Expanding Regional Airports Act; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; S.615 Cabin Air Safety Act of 2023; S.1939FAA Reauthorization Act of 2023; S.1550 Lower Fees, Better Airports Act of 2023;H.R.3896, S 1055 Airport Infrastructure Resilience Act of 2023; S.641 FREEBIRD Act; H.R.125 Travel Mask Mandate Repeal Act of 2023.

Client expense: Not reported · Firm income: $20,000

H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 2243 - Palliative Care and Hospice Education and Training Act; a bill amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care. Efforts to reauthorize the Pandemic and All-Hazards Preparedness Act Efforts regarding the nomination and confirmation of new National Institutes of Health Director Comments in response to Medical Devices; Laboratory Developed Tests Proposed Rule Comments in response to modernizing the National Institutes of Health and Centers for Disease Control and Prevention Comments related to healthcare affordability Efforts related to breast screening recommendations by the United States Preventative Services Taskforce Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to reforms to the United States Preventative Services Taskforce

legislation as it relates to airlines/airports- H.R.103 To prohibit the Secretary of Transportation, acting through the Administrator of the Federal Aviation Administration, from setting a requirement that air carriers and foreign air carriers must require an individual to test negative for COVID-19 to travel in air transportation on an air carrier, and for other purposes; . H.R.2558,S1255 To amend title 49, United States Code, to include a public airport in use by an air reserve station as a primary airport;S.1055 Airport Infrastructure Resilience Act of 2023; H.R.1499 and S753 Good Jobs for Good Airports Act; S.1046 - Small Airport Regulation Relief Act of 2023; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; H.R.1049 Protecting Airport Communities from Particle Emissions Act; H.R.2467 Supporting Middle Americas Airports Act; H.R.1499 and S753 - Good Jobs for Good Airports Act; H.R.2670 National Defense Authorization Act for Fiscal Year 2024 S.2226 National Defense Authorization Act for Fiscal Year 2024; H.R.2916 Expanding Regional Airports Act; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; S.615 Cabin Air Safety Act of 2023; S.1939FAA Reauthorization Act of 2023; S.1550 Lower Fees, Better Airports Act of 2023;H.R.3896, S 1055 Airport Infrastructure Resilience Act of 2023; S.641 FREEBIRD Act; H.R.125 Travel Mask Mandate Repeal Act of 2023.

Client expense: Not reported · Firm income: $20,000

legislation as it relates to airlines/airports- H.R.103 To prohibit the Secretary of Transportation, acting through the Administrator of the Federal Aviation Administration, from setting a requirement that air carriers and foreign air carriers must require an individual to test negative for COVID-19 to travel in air transportation on an air carrier, and for other purposes; . H.R.2558,S1255 To amend title 49, United States Code, to include a public airport in use by an air reserve station as a primary airport;S.1055 Airport Infrastructure Resilience Act of 2023; H.R.1499 and S753 Good Jobs for Good Airports Act; S.1046 - Small Airport Regulation Relief Act of 2023; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; H.R.1049 Protecting Airport Communities from Particle Emissions Act; H.R.2467 Supporting Middle Americas Airports Act; H.R.1499 and S753 - Good Jobs for Good Airports Act; H.R.2670 National Defense Authorization Act for Fiscal Year 2024 S.2226 National Defense Authorization Act for Fiscal Year 2024; H.R.2916 Expanding Regional Airports Act; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; S.615 Cabin Air Safety Act of 2023; S.1939FAA Reauthorization Act of 2023; S.1550 Lower Fees, Better Airports Act of 2023;H.R.3896, S 1055 Airport Infrastructure Resilience Act of 2023; S.641 FREEBIRD Act; H.R.125 Travel Mask Mandate Repeal Act of 2023.

Client expense: Not reported · Firm income: $20,000

H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 2243 - Palliative Care and Hospice Education and Training Act; a bill amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care. Efforts to reauthorize the Pandemic and All-Hazards Preparedness Act Efforts regarding the nomination and confirmation of new National Institutes of Health Director Comments regarding FDA Draft Guidance Decentralized Clinical Trials for Drugs, Biological Products, and Devices Comments in response to the discussion draft of the Stop Drug Shortages Act Efforts related to breast screening recommendations by the United States Preventative Services Taskforce Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to reforms to the United States Preventative Services Taskforce

H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 1339 - Pharmacy Benefit Manager Reform Act; bill establishes various requirements for pharmacy benefit managers (PBMs) with respect to services provided to health insurance plans Efforts to reintroduce legislation which requires the Department of Health and Human Services (HHS) to take a series of actions relating to palliative-care training known as the Palliative Care and Hospice Education and Training Act Comments regarding the nomination and confirmation of new National Institutes of Health Director Comments in response to a Congressional Request for Information regarding the role and mission of the Centers for Disease Control and Prevention Comments in response to draft recommendations on breast cancer screening release by the United States Preventative Services Taskforce Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to the implementation of the National Cancer Institutes National Cancer Plan Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to reforms to the United States Preventative Services Taskforce

legislation as it relates to airports- H.R.103 To prohibit the Secretary of Transportation, acting through the Administrator of the Federal Aviation Administration, from setting a requirement that air carriers and foreign air carriers must require an individual to test negative for COVID-19 to travel in air transportation on an air carrier, and for other purposes; . H.R.2558 To amend title 49, United States Code, to include a public airport in use by an air reserve station as a primary airport;S.1055 Airport Infrastructure Resilience Act of 2023; H.R.1499 and S753 Good Jobs for Good Airports Act; S.1046 - Small Airport Regulation Relief Act of 2023; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; H.R.1049 Protecting Airport Communities from Particle Emissions Act; H.R.2467 Supporting Middle Americas Airports Act; H.R.1499 and S753 - Good Jobs for Good Airports Act; H.R.2670 National Defense Authorization Act for Fiscal Year 2024 S.2226 National Defense Authorization Act for Fiscal Year 2024; H.R.2916 Expanding Regional Airports Act; H.R.1648 Airport Technology and Efficiency Improvement Act of 2023; S.615 Cabin Air Safety Act of 2023; S.1939FAA Reauthorization Act of 2023

Client expense: Not reported · Firm income: $20,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE